Xtant Medical today priced its current shares offering, looking to raise $11 million in the round. The Belgrade, Mont.-based company plans to float 15 million units at 75¢ per unit. Each unit in the round consists of 1 share of common stock and 1 warrant to purchase another share of stock. The offering opened on October 31, […]
Xtant Medical
Xtant Medical expands Belgrade tissue processing facility
Xtant Medical said today it is expanding its Belgrade, Mont. tissue processing facility to include 7 new processing rooms. The company said the addition will more than double it’s capacity of processing rooms which are available for production. “These facilities allow for increased processing volume of our high-demand products and reduces the time required to get […]
Xtant Medical ticks up on Q2 prelims
Xtant Medical saw shares tick up approximately 2% after releasing preliminary revenue figures for its 2nd quarter that saw and EBITDA up from its 1st quarter. The company said it expects to report revenue between $21.45 million and $21.65 million for the 2nd quarter, which is close to the $21.66 million it reported last year […]
J&J investor relations veep Mehrotra retires, Wolk steps up | Personnel Moves June 22, 2016
J&J investor relations veep Mehrotra retires, Wolk steps up Johnson & Johnson (NYSE:JNJ) said today its 10-year vice president of investor relations Louise Mehrotra will retire, effective January 2017, to be replaced by Joseph Wolk, effective August 1. Wolk previously served as vice president of group finance for Johnson & Johnson’s pharmaceuticals deivision, and has […]
Xtant Medical wins FDA nod for spinal laminoplasty system
Xtant Medical said today its X-Spine Systems subsidiary won FDA 510(k) clearance for its Xspan laminoplasty fixation system designed for use in the lower cervical and upper thoracic spine. Spinal laminoplasty is a surgical procedure designed to remove pressure from the spinal cord through the restructuring of the lamina through a window or opening to allow […]
Xtant, Vivex ink distribution deal for OsteoVive allograft
Xtant Medical said today it inked a distribution deal with Vivex Biomedical to distribute its OsteoVive cellular bone allograft. The new agreement will allow Xtant to enter the cellular bone graft market which the company said is estimated to be between $252 million in 2015 and $400 million in 2019. “Vivex is enthusiastic about teaming up with […]
Xtant Medical wins CE Marks for Aranax, Irix-A spine devices
Xtant Medical said today it won CE Mark approval in the European Union for its Aranax cervical plating system and and Irix-A stand alone anterior lumbar fusion device. The company’s Aranax cervical plating system is distributed as a pre-stereilized, ready-to-use implant. The Irix-A stand alone anterior lumbar fusion device consists of an integrated titanium ring […]
Bacterin to buy X-Spine, rebrand as Xtant Medical in $86m deal
Bacterin (OTC:BONE) yesterday said it agreed to acquire spinal implant maker X-Spine Systems in a cash-and-stock deal worth about $86 million, including the assumption of debt, and rebrand as Xtant Medical Holdings. Belgrade, Mont.-based Bacterin, which makes allograft products using its in-house tissue bank, said the deal includes $60 million in cash, about 4.24 million Bacterin shares and […]